Projects per year
Fingerprint The Fingerprint is created by mining the titles and abstracts of the person's research outputs and projects/funding awards to create an index of weighted terms from discipline-specific thesauri.
- 1 Similar Profiles
gemcitabine
Medicine & Life Sciences
Pancreatic Neoplasms
Medicine & Life Sciences
Neoplasms
Medicine & Life Sciences
Drug Therapy
Medicine & Life Sciences
Adenocarcinoma
Medicine & Life Sciences
Therapeutics
Medicine & Life Sciences
Survival
Medicine & Life Sciences
oxaliplatin
Medicine & Life Sciences
Network
Recent external collaboration on country level. Dive into details by clicking on the dots.
Projects 2001 2022
Phase 1-2 Study of ADI-PEG 20 plus FOLFOX in Subjects withAdvanced Gastrointestinal Malignancies
12/1/17 → 11/30/22
Project: Research project
gemcitabine
Hyaluronoglucosaminidase
Multicenter Studies
Placebos
130-nm albumin-bound paclitaxel
Hepatocellular Carcinoma
Placebos
Safety
MDV 3100
Vaccinia
Thymidine Kinase
Viruses
Hepatocellular Carcinoma
Therapeutics
gemcitabine
Pancreatic Neoplasms
Neoplasms
ALT-803
130-nm albumin-bound paclitaxel
Research Output 1992 2018
8
Citations
(Scopus)
Ruxolitinib + capecitabine in advanced/metastatic pancreatic cancer after disease progression/intolerance to first-line therapy: JANUS 1 and 2 randomized phase III studies
Hurwitz, H., Van Cutsem, E., Bendell, J., Hidalgo, M., Li, C. P., Salvo, M. G., Macarulla, T., Sahai, V., Sama, A., Greeno, E. W., Yu, K. H., Verslype, C., Dawkins, F., Walker, C., Clark, J. & O’Reilly, E. M., Aug 1 2018, In : Investigational New Drugs. 36, 4, p. 683-695 13 p.Research output: Contribution to journal › Article
Pancreatic Neoplasms
Disease Progression
Survival
Confidence Intervals
Disease-Free Survival
17
Citations
(Scopus)
Development of peripheral neuropathy and its association with survival during treatment with nab-paclitaxel plus gemcitabine for patients with metastatic adenocarcinoma of the pancreas: A subset analysis from a randomised phase III trial (MPACT)
Goldstein, D., Von Hoff, D. D., Moore, M., Greeno, E., Tortora, G., Ramanathan, R. K., Macarulla, T., Liu, H., Pilot, R., Ferrara, S. & Lu, B., Jan 1 2016, In : European Journal of Cancer. 52, p. 85-91 7 p.Research output: Contribution to journal › Article
gemcitabine
Peripheral Nervous System Diseases
Pancreas
Adenocarcinoma
Survival
10
Citations
(Scopus)
RNA sequencing of pancreatic adenocarcinoma tumors yields novel expression patterns associated with long-term survival and reveals a role for ANGPTL4
Kirby, M. K., Ramaker, R. C., Gertz, J., Davis, N. S., Johnston, B. E., Oliver, P. G., Sexton, K. C., Greeno, E. W., Christein, J. D., Heslin, M. J., Posey, J. A., Grizzle, W. E., Vickers, S. M., Buchsbaum, D. J., Cooper, S. J. & Myers, R. M., Oct 1 2016, In : Molecular Oncology. 10, 8, p. 1169-1182 14 p.Research output: Contribution to journal › Article
RNA Sequence Analysis
Adenocarcinoma
gemcitabine
Survival
Neoplasms
11
Citations
(Scopus)
Appropriateness of systemic treatments in unresectable metastatic well-differentiated pancreatic neuroendocrine tumors
Strosberg, J. R., Fisher, G. A., Benson, A. B., Anthony, L. B., Arslan, B., Gibbs, J. F., Greeno, E. W., Iyer, R. V., Kim, M. K., Maples, W. J., Philip, P. A., Wolin, E. M., Cherepanov, D. & Broder, M. S., Feb 28 2015, In : World Journal of Gastroenterology. 21, 8, p. 2450-2459 10 p.Research output: Contribution to journal › Article
Neuroendocrine Tumors
Therapeutics
Somatostatin
Physicians
Interventional Radiology
8
Citations
(Scopus)
Neoadjuvant interferon-based chemoradiation for borderline resectable and locally advanced pancreas cancer: A Phase II pilot study
Jensen, E. H., Armstrong, L., Lee, C. K., Tuttle, T. M., Vickers, S. M., Sielaff, T. & Greeno, E. W., Jan 1 2014, In : HPB. 16, 2, p. 131-139 9 p.Research output: Contribution to journal › Article
Pancreatic Neoplasms
Interferons
Chemoradiotherapy
Survival
Neoadjuvant Therapy